NEWPORT BEACH, Calif., May 16, 2017 — Hoag Memorial Hospital Presbyterian announced today it has named Michael J. Demeure, M.D., F.A.C.S, M.B.A., F.A.C.E, to serve as Program Director of Hoag Precision Medicine, a new program focused on tailoring cancer treatment options for each individual patient.
In his new role, Dr. Demeure will lead the strategy and development for the program, as well as identify new partners, develop a Hoag molecular tumor board and assess new software development.
“We are honored to have Dr. Demeure lead the Hoag Precision Medicine program,” said Burton Eisenberg, M.D., Grace E. Hoag Executive Medical Director Endowed Chair and professor of Clinical Surgery, Keck School of Medicine of USC. “This emerging approach for treatment will give clinicians a clear profile of a patient’s tumor genome abnormalities, and relevant information to offer more precise treatment options.”
Previously only accessible at large academic medical centers, Hoag Family Cancer Institute now utilizes precision medicine through genomic profiling, to hone in on the precise molecular abnormalities that create and sustain cancerous tumors. All tumors have molecular mutations in their DNA. By testing the molecular profile of the tumor cells, doctors can discover what mutations a particular tumor has and tailor a treatment specifically to that mutation. Currently, Hoag has applied this technique to provide targeted approaches to many different tumor types.
Dr. Demeure, a fellowship-trained endocrine surgeon, has been in academic surgical practice since 1991. His recent positions include Executive Vice President & Chief Medical Officer at Ashion®; Professor and Director of the Endocrine and Rare Tumors Program in the Division of Integrated Cancer Genomics at Translational Genomics Research Institute (TGen); and Teaching Surgeon for the General Surgery Residency Training Program for Maricopa Integrated Health System. Dr. Demeure graduated from the Hahnemann Medical College and completed his surgical residency at the University of Arizona, where he also earned his MBA and later served as Professor & Chief of General Surgery. He completed a fellowship in endocrine surgery in Perth, Australia, and at the University of California, San Francisco. As an internationally recognized expert in cancer surgery and research, he has published more than 100 scholarly works.
ABOUT HOAG MEMORIAL HOSPITAL PRESBYTERIAN
Hoag is an approximately $1 billion nonprofit, regional health care delivery network in Orange County, California, that treats more than 29,000 inpatients and 305,000 outpatients annually. Hoag consists of two acute-care hospitals – Hoag Hospital Newport Beach, which opened in 1952, and Hoag Hospital Irvine, which opened in 2010 – in addition to seven health centers and ten urgent care centers. Hoag is a designated Magnet® hospital by the American Nurses Credentialing Center (ANCC). Hoag offers a comprehensive blend of health care services that includes five institutes providing specialized services in the following areas: cancer, heart and vascular, neurosciences, women’s health, and orthopedics through Hoag’s affiliate, Hoag Orthopedic Institute, which consists of an orthopedic hospital and two ambulatory surgical centers. In 2013, Hoag entered into an alliance with St. Joseph Health to further expand health care services in the Orange County community, known as St. Joseph Hoag Health. Hoag has been named one of the Best Regional Hospitals in the 2016 – 2017 U.S. News & World Report, and Becker’s Hospital Review named Hoag as one of the 2016 “100 Great Hospitals in America” – a designation Hoag has received four times. National Research Corporation has endorsed Hoag as Orange County’s most preferred hospital for the past 20 consecutive years and, for an unprecedented 21 years, residents of Orange County have chosen Hoag as one of the county’s best hospitals in a local newspaper survey. Visit www.hoag.org for more information.
# # #
